254723124	254723124	CD	B-NP	O
|	|	NN	I-NP	O
NMC	NMC	NN	I-NP	O
|	|	NN	I-NP	O
02022883	02022883	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4889850	4889850	CD	B-NP	O
|	|	CC	I-NP	O
9/6/2005	9/6/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Asthma	Asthma	NNP	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/10/2005	11/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/14/2005	4/14/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
REINHOLTZ	REINHOLTZ	NN	B-NP	O
,	,	,	O	O
IVORY	IVORY	NN	B-NP	O
399-30-62-7	399-30-62-7	CD	I-NP	O
Minfran	Minfran	NNP	I-NP	O
Cin	Cin	NNP	I-NP	O
Geneli	Geneli	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/26/05	9/26/05	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STRUVE	STRUVE	NN	B-NP	O
,	,	,	O	O
FRANCISCO	FRANCISCO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
CARDIZEM	CARDIZEM	NN	I-NP	O
SR	SR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
SUSTAINED	SUSTAINED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/5/05	1/5/05	CD	B-NP	O
by	by	IN	B-PP	O
DUHART	DUHART	NNP	B-NP	O
,	,	,	O	O
RANDY	RANDY	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LOPRESSOR	LOPRESSOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
90154262	90154262	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/9/05	4/9/05	CD	B-NP	O
by	by	IN	B-PP	O
EHRHARD	EHRHARD	NNP	B-NP	O
,	,	,	O	O
STANLEY	STANLEY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
99	99	CD	B-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	O
25	25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/9/05	4/9/05	CD	B-NP	O
by	by	IN	B-PP	O
JACQUEMIN	JACQUEMIN	NNP	B-NP	O
,	,	,	O	O
FOREST	FOREST	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
12145723	12145723	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
LOPRESSOR	LOPRESSOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/5	9/5	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
HR	HR	NN	B-NP	B-protein
<	<	SYM	B-ADJP	I-protein
50	50	CD	B-NP	I-protein
,	,	,	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NNP	B-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/9/05	4/9/05	CD	B-NP	O
by	by	IN	B-PP	O
BOILEAU	BOILEAU	NN	B-NP	O
,	,	,	O	O
RAYFORD	RAYFORD	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CARDIZEM	CARDIZEM	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
41464376	41464376	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/9/05	4/9/05	CD	B-NP	O
by	by	IN	B-PP	O
UPHOLD	UPHOLD	NNP	B-NP	O
,	,	,	O	O
DONNY	DONNY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CARDIZEM	CARDIZEM	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
87162289	87162289	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	NN	B-NP	B-protein
PREDNISONE	PREDNISONE	NN	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QAM	QAM	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
10	10	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Starting	Start	VBG	B-VP	I-protein
Today	Today	NN	B-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
9/5	9/5	CD	I-NP	I-protein
-RRB-	-RRB-	NNPS	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Taper	Taper	NNP	B-NP	O
:	:	:	O	O
40mg	40mg	CD	B-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
35mg	35mg	CD	B-NP	O
for	for	IN	B-PP	O
2days	2day	NNS	B-NP	O
,	,	,	O	O
then	then	RB	O	O
30mg	30mg	CD	B-NP	O
for	for	IN	B-PP	O
2days	2day	NNS	B-NP	O
,	,	,	O	O
then	then	RB	O	O
25mg	25mg	CD	B-NP	O
for	for	IN	B-PP	O
2days	2day	NNS	B-NP	O
,	,	,	O	O
then	then	RB	O	O
20mg	20mg	CD	B-NP	O
indefinitely	indefinitely	RB	I-NP	O
.	.	.	O	O

ZOCOR	ZOCOR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
CALCIUM	CALCIUM	NN	I-NP	I-protein
CARB	CARB	NN	I-NP	I-protein
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
600MG	600MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-NP	O
VIT	VIT	NN	I-NP	O
D/200	D/200	NN	I-NP	O
IU	IU	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
ATOVAQUONE	ATOVAQUONE	NN	I-NP	O
750	750	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
NAPROSYN	NAPROSYN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NAPROXEN	NAPROXEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
250-500	250-500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/26/05	9/26/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLOPIDOGREL	CLOPIDOGREL	NNP	B-NP	O
BISULFATE	BISULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
NAPROXEN	NAPROXEN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
musculoskeletal	musculoskeletal	JJ	B-NP	O
pain	pain	NN	I-NP	O
ADVAIR	ADVAIR	NN	I-NP	O
DISKUS	DISKUS	VBZ	B-VP	O
500/50	500/50	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
BALVANZ	BALVANZ	NNP	I-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
asthma	asthma	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Asthma	Asthma	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
NSTEMI	NSTEMI	NNP	I-NP	O
,	,	,	O	O
stent	stent	JJ	B-ADJP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
OBESITY	OBESITY	NN	I-NP	O
OSA	OSA	NN	I-NP	O
HTN	HTN	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
2/2	2/2	CD	I-NP	O
chronic	chronic	JJ	I-NP	O
steroid	steroid	NN	I-NP	O
use	use	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ECHO	ECHO	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
Yo	Yo	NN	I-NP	O
obese	obese	JJ	I-NP	O
F	F	NN	I-NP	O
ho	ho	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
,	,	,	O	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
prednisone	prednisone	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
in	in	IN	B-PP	O
9/21	9/21	CD	B-NP	O
w	w	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
presents	present	VBZ	B-VP	O
w	w	NN	B-NP	B-protein
SOB	SOB	NN	I-NP	I-protein
x	x	SYM	B-VP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
USH	USH	NN	B-NP	O
until	until	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
sudden	sudden	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
feels	feel	NNS	I-NP	O
heavy	heavy	JJ	B-ADJP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
,	,	,	O	O
sometimes	sometimes	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
when	when	WRB	B-ADVP	O
taking	take	VBG	B-VP	O
a	a	DT	B-NP	O
deep	deep	JJ	I-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
since	since	IN	B-PP	O
onset	onset	NN	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
tightness	tightness	NN	I-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
more	more	RBR	B-ADJP	O
severe	severe	JJ	B-NP	O
and	and	CC	I-NP	O
worse	worse	JJR	I-NP	O
w	w	NN	I-NP	O
exertion	exertion	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
occasionally	occasionally	RB	B-ADVP	O
gets	get	VBZ	B-VP	O
palpitations	palpitation	NNS	B-NP	O
since	since	IN	B-PP	O
her	her	PRP$	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
N/V/diaphoresis	N/V/diaphoresis	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
developed	develop	VBN	I-VP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
cough	cough	NN	I-NP	O
over	over	IN	B-PP	O
past	past	JJ	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sick	sick	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lower	low	JJR	I-NP	O
ext	ext	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
stable	stable	JJ	B-NP	O
3-pillow	3-pillow	JJ	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	I-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
BP	BP	NN	B-NP	O
170/105	170/105	CD	B-NP	O
HR	HR	NN	I-NP	O
80	80	CD	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
AOx3	AOx3	NN	B-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	O
8cm	8cm	NN	I-NP	O
,	,	,	O	O
sternum	sternum	NN	B-NP	O
tender	tender	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
,	,	,	O	O
bilat	bilat	NN	B-NP	O
exp	exp	NN	I-NP	O
wheezes	wheeze	VBZ	B-VP	O
throughout	throughout	IN	B-ADVP	O
,	,	,	O	O
prolonged	prolonged	JJ	B-NP	O
expiratory	expiratory	JJ	I-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
s1	s1	NN	B-NP	B-protein
s2	s2	NN	I-NP	I-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
c/c/e	c/c/e	NN	I-NP	O
labs	lab	NNS	I-NP	O
:	:	:	O	O
trop	trop	VB	B-VP	O
neg	neg	NN	B-NP	O
x3	x3	NN	I-NP	O
,	,	,	O	O
D-dimer	D-dimer	NN	B-NP	O
<	<	SYM	B-VP	O
200	200	CD	B-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	O
19	19	CD	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
Axis	Axis	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	B-protein
changes	change	NNS	I-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
:	:	:	O	O
lungs	lung	NNS	B-NP	O
clear	clear	VBP	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
costophrenic	costophrenic	JJ	B-NP	O
sulci	sulci	NN	I-NP	O
sharp	sharp	JJ	I-NP	O
bilat	bilat	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
pulm	pulm	NN	I-NP	O
process	process	NN	I-NP	O
45	45	CD	I-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
,	,	,	O	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
recent	recent	JJ	I-NP	O
MI	MI	NN	I-NP	O
w	w	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
asthma	asthma	NN	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
prednisone	prednisone	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
w	w	JJ	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
worsening	worsen	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
asthma	asthma	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
w	w	NN	I-NP	O
prednisone	prednisone	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
relief	relief	NN	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
,	,	,	O	O
recent	recent	JJ	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
ho	ho	JJ	B-NP	O
PND	PND	NN	I-NP	O
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
considered	consider	VBN	B-VP	O
both	both	CC	O	O
cardiac	cardiac	JJ	B-NP	O
and	and	CC	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
etiologies	etiology	NNS	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
ROMI	ROMI	NN	B-NP	O
with	with	IN	B-PP	O
neg	neg	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
x3	x3	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
ECG	ECG	NN	B-NP	B-protein
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
shows	show	VBZ	B-VP	O
concentric	concentric	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
but	but	CC	O	O
EF	EF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
or	or	CC	O	O
systolic/diastolic	systolic/diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
,	,	,	I-NP	O
TnI	TnI	NN	I-NP	O
normal	normal	JJ	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
8cm	8cm	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
subjective	subjective	JJ	B-NP	O
palpitations	palpitation	NNS	I-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
arrhythmia	arrhythmia	NN	B-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
one	one	CD	B-NP	O
brief	brief	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
apparent	apparent	JJ	B-NP	O
broad-complex	broad-complex	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
which	which	WDT	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
closer	close	JJR	B-NP	O
inspection	inspection	NN	I-NP	O
and	and	CC	I-NP	O
review	review	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
EP	EP	NN	I-NP	O
fellow	fellow	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
clearly	clearly	RB	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
artefactual	artefactual	JJ	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
observed	observe	VBN	B-VP	O
throughout	throughout	IN	B-ADVP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
zocor	zocor	NN	B-NP	O
,	,	,	O	O
clopidogrel	clopidogrel	NN	B-NP	O
,	,	,	O	O
ECASA	ECASA	NN	B-NP	B-protein
.	.	.	O	O

nitrates	nitrate	NNS	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
HCTZ	HCTZ	NN	B-NP	B-protein
,	,	,	O	O
cardizem	cardizem	NN	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
.	.	.	O	O

stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Pulm	Pulm	NNP	B-NP	O
:	:	:	O	O
Dyspnea	Dyspnea	NNP	B-NP	O
and	and	CC	O	O
wheezing	wheeze	VBG	B-VP	O
w	w	NN	B-NP	O
ho	ho	JJ	I-NP	O
multiple	multiple	JJ	I-NP	O
asthma	asthma	NN	I-NP	O
exacerbations	exacerbation	NNS	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

Never	Never	RB	B-ADVP	O
hospitalized	hospitalize	VBN	B-VP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
prednisone	prednisone	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

s/p	s/p	NN	B-NP	O
gentle	gentle	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
pred	pre	VBD	B-VP	O
,	,	,	O	O
nebs	neb	NNS	B-NP	O
w	w	VBP	B-VP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

D-dimer	D-dimer	NN	B-NP	O
<	<	SYM	B-VP	O
200	200	CD	B-NP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	B-protein
peak	peak	NN	I-NP	I-protein
flow	flow	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
baseline	baseline	NN	I-NP	I-protein
nl	nl	NN	I-NP	I-protein
300-350	300-350	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
275-300	275-300	CD	I-NP	O
.	.	.	O	O

Ambulatory	Ambulatory	JJ	B-NP	O
O2	O2	NN	I-NP	O
sat	sit	VBD	B-VP	O
WNL	WNL	NNP	B-NP	B-cell_type
-	-	HYPH	O	O
Combivent	Combivent	NNP	B-NP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
,	,	,	O	O
steroid	steroid	NN	B-NP	O
taper	taper	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
40mg	40mg	CD	B-NP	O
to	to	TO	B-PP	O
20mg	20mg	CD	B-NP	O
over	over	IN	I-NP	O
8	8	CD	I-NP	O
days	day	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	O
ppx	ppx	NN	I-NP	O
with	with	IN	B-PP	O
BID	BID	NN	B-NP	O
Atovaquone	Atovaquone	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
prednisone	prednisone	NN	I-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
steroid	steroid	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
Insulin	Insulin	NN	B-NP	B-protein
SS	SS	NN	I-NP	O
in-house	in-house	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
calcium/vit	calcium/vit	NN	I-NP	O
D	D	NN	I-NP	O
supplement	supplement	NN	I-NP	O
.	.	.	O	O

MUSC	MUSC	NN	B-NP	B-protein
:	:	:	O	O
Reproducible	Reproducible	JJ	B-NP	O
sternal	sternal	JJ	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
costochondritis	costochondritis	NN	B-NP	O
.	.	.	O	O

Naprosyn	Naprosyn	NN	B-NP	O
PRN	PRN	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
Continue	Continue	NNP	B-NP	O
Zoloft	Zoloft	NNP	I-NP	O
for	for	IN	B-PP	O
depression	depression	NN	B-NP	O
and	and	CC	I-NP	O
Lorazepam	Lorazepam	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

PPx	PPx	NN	B-NP	B-protein
:	:	:	O	O
PPI	PPI	NNP	B-NP	O
FULL	FULL	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
or	or	CC	O	O
come	come	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
swelling	swell	VBG	B-VP	O
in	in	IN	B-PP	O
legs	leg	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Assess	Assess	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
20mg	20mg	NN	I-NP	O
upon	upon	IN	B-PP	O
completion	completion	NN	B-NP	O
of	of	IN	B-PP	O
taper	taper	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
dyspnea/asthma	dyspnea/asthma	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
chest	chest	NN	I-NP	O
pain/costochondritis	pain/costochondritis	NN	I-NP	O
with	with	IN	B-PP	O
PRN	PRN	NN	B-NP	O
NSAIDs	NSAID	NNS	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
compliance	compliance	NN	I-NP	O
with	with	IN	B-PP	O
atovaquone	atovaquone	NN	B-NP	O
ppx	ppx	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KEPNER	KEPNER	NN	B-NP	O
,	,	,	O	O
KENDRICK	KENDRICK	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
XM83	XM83	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/26/05	9/26/05	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

